»Ê¼Ò»ªÈË

XClose

»Ê¼Ò»ªÈËews

Home
Menu

Improved metrics for Huntington's disease trials

4 June 2018

Professor Sarah Tabrizi (UCL Institute of Neurology) says we're in a 'new era' of Huntington's disease clinical trials, and discusses the drug trial with Ionis Pharmaceuticals that she finalised this year. ,